The straight answer is that the VA has not published a separate yes-or-no coverage page for Ozempic by brand name. For VA weight management, the published rule is about semaglutide as a nonformulary medication with criteria for use. Those criteria require a structured lifestyle intervention program, such as MOVE!, plus a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related comorbidity [4][5]. The VA care team makes the final decision. Ozempic is listed by TRICARE and CHAMPVA for type 2 diabetes, but those are different benefit rules [1][2].

Is Ozempic covered by the VA for weight loss?

The VA facts available here do not support a simple brand-name yes or no. They document that semaglutide is available at the VA as a nonformulary medication with criteria for use for weight management, as of August 2024 [5]. Nonformulary means the medication sits outside the standard formulary and requires the applicable criteria before the VA considers it.

The published VA criteria have a clear shared foundation. You need participation in a structured lifestyle intervention program, which the VA calls a CLI, and you need either a BMI of 30 or higher or a BMI of 27 or higher with at least one weight-related comorbidity [4]. The VA says weight management medications should be used with a CLI, such as MOVE! or a community-based program that offers one [4].

That does not turn into an automatic approval. Each medication has additional criteria of its own, and the common exclusions include pregnancy, breastfeeding, and a hypersensitivity reaction to the medication [4]. The final call sits with your VA care team, using the current VA formulary and criteria that apply when they review your request.

The VA GLP-1 criteria for use page goes deeper into the published gate. You can also use the coverage hub to compare the VA rules with other federal programs.

Why does the answer change when the diagnosis is type 2 diabetes?

Ozempic appears in the federal coverage rules for type 2 diabetes, but the program matters. TRICARE still covers Ozempic, Mounjaro, Trulicity, and Victoza for all patients to treat diabetes when medically necessary [2]. CHAMPVA covers Mounjaro, Ozempic, Rybelsus, Trulicity, and Victoza for type 2 diabetes [1].

Those facts do not create a VA rule for Ozempic by brand name. They show why you should not copy a TRICARE or CHAMPVA answer into a VA request. A veteran receiving VA care follows the VA formulary and VA criteria. A spouse or child using CHAMPVA follows CHAMPVA rules. A retiree using TRICARE For Life follows the TRICARE rules for that plan.

The diagnosis also matters because weight management criteria and diabetes treatment criteria are not the same question. The VA material here documents semaglutide in the weight management context, with a CLI, BMI threshold, comorbidity pathway, common exclusions, and drug-specific criteria [4][5]. It does not document a separate VA page saying Ozempic is covered for type 2 diabetes.

Ask your VA care team which indication they are evaluating and which current criteria for use apply. Bring the medication name, the diagnosis being treated, and any prior VA documentation. The care team, not a search result, has the final word for your VA request.

What does nonformulary mean for a VA prescription?

A formulary is the medication list a health program uses as its standard coverage framework. Nonformulary means a medication is outside that standard list and is considered through a separate criteria process. For VA weight management, the available facts state that semaglutide is nonformulary with criteria for use [5].

That label is important because it tells you what the next conversation is about. You are not asking only whether the VA carries semaglutide. You are asking whether your situation matches the published weight management criteria and any additional criteria for that medication.

The shared VA gate includes a CLI that targets nutrition, physical activity, and behavior [4]. It also includes BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity. The VA examples are hypertension, type 2 diabetes, dyslipidemia, metabolic syndrome, obstructive sleep apnea, osteoarthritis, and MASLD [4].

The VA also lists common exclusions of pregnancy, breastfeeding, and a hypersensitivity reaction to the medication [4]. These are not the complete drug-specific rules. The VA source says each medication has additional criteria of its own.

So, nonformulary does not answer the question by itself. It tells you to ask about criteria for use. The VA weight loss program article explains how MOVE! fits into that process. Your VA care team then reviews the facts in your record and gives the decision that applies to you.

Does MOVE! satisfy the VA lifestyle requirement?

MOVE! is the VA weight management program for veterans. The VA says it offers an evidence-based lifestyle program and that it has helped hundreds of thousands of veterans [4]. The VA also says weight management medications should be used together with a structured lifestyle intervention program, such as MOVE! or a community-based program that offers one [4].

That makes MOVE! the practical program to ask about when you are discussing semaglutide for weight management with your VA care team. The published criteria call the requirement a CLI. The program must target nutrition, physical activity, and behavior [4].

Participation in MOVE! is one part of the criteria, not the whole decision. You still need the BMI pathway, either BMI 30 or higher or BMI 27 or higher with at least one listed weight-related comorbidity [4]. Pregnancy, breastfeeding, and a hypersensitivity reaction to the medication are common exclusions, and the medication can have additional criteria of its own [4].

The facts do not document a single VA participation duration or a separate Ozempic-specific MOVE! rule. Do not fill that gap with a number from a different program. Ask your VA care team how your MOVE! record or another CLI will be counted under the current VA criteria.

You can use the VA weight loss program guide before the appointment, then ask the care team to match your record to the current criteria for use.

How do TRICARE and CHAMPVA treat Ozempic?

The comparison is useful only if you keep the programs separate. CHAMPVA does not cover GLP-1 medications prescribed for weight loss. For type 2 diabetes, CHAMPVA covers Mounjaro, Ozempic, Rybelsus, Trulicity, and Victoza [1]. CHAMPVA also covers Zepbound for moderate to severe obstructive sleep apnea verified by a sleep study within the past 12 months, and Wegovy for MASH or prevention of MACE. Wegovy and Zepbound require prior authorization through OptumRx at 844-403-1029 [1].

TRICARE still covers Ozempic, Mounjaro, Trulicity, and Victoza for all patients to treat diabetes when medically necessary [2]. For weight loss, the rule is different.

As of August 31, 2025, TRICARE stopped covering weight loss drugs for TRICARE For Life and direct-care-only beneficiaries, and NATO or Partnership for Peace members, while TRICARE Prime and TRICARE Select plus the premium-based plans listed by the source keep coverage behind prior authorization. Approved prior authorizations for excluded beneficiaries are no longer valid [2][3].

That split does not decide your VA request. It does give you a useful warning. The word covered has no meaning without the program, diagnosis, and indication attached to it. A CHAMPVA diabetes rule, a TRICARE diabetes rule, and a VA weight management criteria-for-use process are separate lanes.

Here is the VA weight management checklist to take to your appointment.

  • Participate in a structured lifestyle intervention program, called a CLI, that targets nutrition, physical activity, and behavior [4].
  • Have a BMI of 30 or higher [4].
  • Or have a BMI of 27 or higher plus at least one weight-related comorbidity [4].
  • Match one of the VA-listed comorbidities, hypertension, type 2 diabetes, dyslipidemia, metabolic syndrome, obstructive sleep apnea, osteoarthritis, or MASLD [4].
  • Check the common exclusions, pregnancy, breastfeeding, and a hypersensitivity reaction to the medication [4].
  • Ask the VA care team about additional criteria for semaglutide, because each weight management medication has its own criteria [4].

What to do next

Written for a veteran asking the VA care team about weight management medication this week:

  1. Write down whether your question concerns weight management, type 2 diabetes, or another documented indication.
  2. Check your VA record for BMI documentation and the weight-related comorbidity that may fit the published criteria [4].
  3. Ask the VA care team whether MOVE! or another CLI is available and how your participation will be documented [4].
  4. Bring the exact name Ozempic to the appointment, but ask the team to review semaglutide criteria for use rather than relying on a brand-name search result.
  5. Ask whether semaglutide is being considered as a nonformulary medication under the current VA process [5].
  6. Review pregnancy, breastfeeding, and hypersensitivity exclusions with the care team before asking about the additional drug-specific criteria [4].
  7. Ask for the current VA formulary and criteria-for-use document that applies to your request.
  8. Keep the care team's written decision, any denial letter, and the criteria document together for your records.
  9. If you also have CHAMPVA or TRICARE coverage in your household, check that program's official rule separately instead of using the VA answer [1][2].

Sources

  1. VA Community Care, CHAMPVA program page, CHAMPVA indications and OptumRx prior authorization, accessed 2026-08-01, https://department.va.gov/vha/community-care/family-member-care/champva/
  2. TRICARE, Weight Loss Products coverage page, diabetes and weight loss coverage rules, accessed 2026-08-01, https://tricare.mil/weightlossproducts
  3. myAirForceBenefits, TRICARE coverage of weight loss medications, August 31, 2025 coverage change, accessed 2026-08-01, https://myairforcebenefits.us.af.mil/TRICARE-Coverage-of-Weight-Loss-Medications-What-To-Know
  4. VA PBM Academic Detailing, Weight Management A VA Clinician Summary (2025), VA criteria for use and MOVE!, accessed 2026-08-01, https://www.pbm.va.gov/PBM/AcademicDetailingService/Documents/508/IB10-1784_WeightMgmt-ClinicianSummary_P97235.pdf
  5. U.S. Medicine, 2025 Compendium of Federal Medicine, VA nonformulary weight management medications, accessed 2026-08-01, https://www.usmedicine.com/2025-compendium-of-federal-medicine/determining-what-weight-loss-medications-are-best-for-veterans/